Evidence map›Paper›PMID 39538054›Full record

ArticleJournal of bioenergetics and biomembranes2024

Effects of MMP2 and its inhibitor TIMP2 on DNA damage, apoptosis and senescence of human lens epithelial cells induced by oxidative stress.

Xinran Deng, Yan Zhang, Xiwei He, Li Li, Zhongbin Yue, Yong Liang, Yue Huang

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of bioenergetics and biomembranes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Target identification and assessment in the era of AI.Nature reviews. Drug discovery · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. The role of MMPs in intracerebral hemorrhage.Frontiers in cell and developmental biology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xinran DengPengzhou People's Hospital Ophthalmology Department, Chengdu City, 611930, Sichuan Province, China.
Yan ZhangPengzhou People's Hospital Ophthalmology Department, Chengdu City, 611930, Sichuan Province, China.
Xiwei HePengzhou People's Hospital Ophthalmology Department, Chengdu City, 611930, Sichuan Province, China.
Li LiPengzhou People's Hospital Ophthalmology Department, Chengdu City, 611930, Sichuan Province, China.
Zhongbin YuePengzhou People's Hospital Ophthalmology Department, Chengdu City, 611930, Sichuan Province, China.
Yong LiangPengzhou People's Hospital Ophthalmology Department, Chengdu City, 611930, Sichuan Province, China. YongliangDr@163.com.
Yue HuangTianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, 300384, China. YuehuangDr@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxidative stress-induced lens epithelial cells (LECs) death plays a pivotal role in pathogenesis of age-related cataract (ARC), causing significant visual impairment. Apoptosis of porcine granulosa cells mediated by MMP2 is linked to DNA damage. The current study aimed to investigate the potential mechanism of MMP2 in DNA damage, apoptosis and senescence of lens epithelial cells caused by oxidative stress. HLE-B3 cells were treated with different doses of H

Indexed as

ApoptosisCellular SenescenceDNA DamageEpithelial CellsLens, CrystallineMatrix Metalloproteinase 2Oxidative StressTissue Inhibitor of Metalloproteinase-2Cell LineHumansHydrogen PeroxideHydrogen PeroxideMatrix Metalloproteinase 2MMP2 protein, humanTIMP2 protein, humanTissue Inhibitor of Metalloproteinase-2ARCDNA damageLECsMMP2SenescenceTIMP2

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.